WallStreetZenWallStreetZen

NASDAQ: RAPP
Rapport Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Rapport Therapeutics earnings were -$79.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RAPP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$24.1M, up 20.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RAPP reported annual earnings of -$78.3M, with 125.1% growth.

RAPP earnings history

Current Revenue
$0.0
Current Earnings
-$79.7M
Current Profit Margin
0%

RAPP Return on Equity

Current Company
-25.5%
Current Industry
-60.2%
Current Market
31.5%
RAPP's Return on Equity (-25.5%)... subscribe to Premium to read more.
High Return on Equity Performance

RAPP undefined

Current Company
-24.6%
Current Industry
-2.5%
RAPP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RAPP announces earnings.

RAPP undefined

Current Company
-27.23%
Current Industry
5.8%

RAPP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RAPP-$77.87M-$79.70MN/A-$3.00
TECX-$55.94M-$58.67MN/A-$6.14
ERAS-$153.97M-$157.60MN/A-$0.60
SAGE-$353.59M-$354.40MN/A-$5.80
BNTC-$24.79M-$27.11MN/A$0.00
View Top Biotech Stocks

Rapport Therapeutics Earnings Reports & History FAQ

What were Rapport Therapeutics's earnings last quarter?

Rapport Therapeutics (NASDAQ: RAPP) reported Q1 2025 earnings per share (EPS) of -$0.68, up 93.86% year over year. Total RAPP earnings for the quarter were -$24.06 million. In the same quarter last year, Rapport Therapeutics's earnings per share (EPS) was -$11.07.

If you're new to stock investing, here's how to buy Rapport Therapeutics stock.

Is Rapport Therapeutics profitable or losing money?

As of the last Rapport Therapeutics earnings report, Rapport Therapeutics is currently losing money. Rapport Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$79.70 million, a 55.34% increase year over year.

What was RAPP's earnings growth in the past year?

As of Rapport Therapeutics's earnings date in Q2 2025, Rapport Therapeutics's earnings has grown year over year. RAPP earnings in the past year totalled -$79.70 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.